BOSTON, MA--(Marketwire - April 06, 2009) - PHT Corporation announced that John J. Arcari, CPA, MBA, joined the company as Chief Financial Officer, reporting directly to PHT President and CEO Phil Lee. PHT is the leading provider of electronic patient reported outcome (ePRO) solutions used in more than 390 clinical trials worldwide.
Mr. Arcari has 25 years of successful experience in finance. His broad areas of expertise include public and private financings, mergers and acquisitions, joint ventures, international operations, and successful enterprise system implementations.
PHT’s Phil Lee said, “John Arcari is a business leader with a proven track record in a wide range of financial and administrative areas. We expect 2009 to be a strong growth year, and John is the ideal executive to develop strategies that will improve PHT’s profitability and operating margins. I look forward to working with John to bring our finance, HR, legal and other key functions to the next level.”
Mr. Arcari has a track record of providing sound financial planning and execution capabilities to rapidly growing technology and life sciences corporations. Previously he was a CFO consultant with Tatum, LLC, the fastest-growing executive financial services and consulting firm in the US. Prior to Tatum, he was CFO at CRF Inc, a provider of electronic patient diaries; Organogensis, the publicly held world leader in tissue engineering; and LTX Corporation, a publicly held provider of semiconductor capital equipment.
Mr. Arcari received his MBA in Finance, and BS in Accounting from New Mexico State University. His memberships include the American Institute of CPAs, the Massachusetts Society of CPAs, the Massachusetts Biotechnology Council, The Financial Executives Institute, and the Association for Corporate Growth.
About PHT Corporation
PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 390 clinical trials by 100 biopharmaceutical clients. The proven LogPad® System and revolutionary SitePad™ Tablet deliver the voice of the patient, in 80 languages, from homes and sites in 60 countries around the world. By capturing high-quality and time-stamped assessments with minimal respondent burden, trial sponsors are able to run smaller and more conclusive clinical research programs resulting in significant R&D cost savings. Real-time study management through PHT StudyWorks™ features eClinical data integration, standard and custom data summaries for compliance and enrollment, SafetyPRO™ email alerts, and the industry’s premier study archive. Patient experiences captured firsthand by PHT’s ePRO Product Suite have been used successfully in at least 11 NDA submissions and seven approvals to date. For more information, review interactive product demonstrations at the award-winning www.phtcorp.com
PHT, LogPad, eSense, StudyWorks, SafetyPRO and SitePad are among the registered trademarks and trademarks of PHT Corporation.
Contact:
Brenda Nashawaty
Email Contact
617-688-3253
